Document:

Exhibit 10.1

 

Form
Of

INDEMNIFICATION AGREEMENT

 

THIS INDEMNIFICATION
AGREEMENT (the “Agreement”) is made and entered into as of _______, 2020 between Immunome, Inc., a Delaware
corporation (the “Company”), and _____________________________________ (“Indemnitee”).

 

WITNESSETH THAT:

 

WHEREAS, highly
competent persons have become more reluctant to serve corporations as directors or in other capacities unless they are provided
with adequate protection through insurance or adequate indemnification against inordinate risks of claims and actions against them
arising out of their service to and activities on behalf of the corporation;

 

WHEREAS, the
Board of Directors of the Company (the “Board”) has determined that, in order to attract and retain qualified
individuals, the Company will attempt to maintain on an ongoing basis, at its sole expense, liability insurance to protect persons
serving the Company and its subsidiaries from certain liabilities. Although the furnishing of such insurance has been a customary
and widespread practice among U.S.-based corporations and other business enterprises, the Company believes that, given current
market conditions and trends, such insurance may be available to it in the future only at higher premiums and with more exclusions.
At the same time, directors, officers, and other persons in service to corporations or business enterprises are being increasingly
subjected to expensive and time-consuming litigation relating to, among other things, matters that traditionally would have been
brought only against the Company or business enterprise itself. The Company’s Bylaws (the “Bylaws”) and
the Company’s Certificate of Incorporation (the “Certificate of Incorporation”) require indemnification
of the officers and directors of the Company. Indemnitee may also be entitled to indemnification pursuant to the General Corporation
Law of the State of Delaware (the “DGCL”). The Bylaws and Certificate of Incorporation and the DGCL expressly
provide that the indemnification provisions set forth therein are not exclusive, and thereby contemplate that contracts may be
entered into between the Company and members of the Board, officers and other persons with respect to indemnification;

 

WHEREAS, the
uncertainties relating to such insurance and to indemnification have increased the difficulty of attracting and retaining such
persons;

 

WHEREAS, the
Board has determined that the increased difficulty in attracting and retaining such persons is detrimental to the best interests
of the Company and its stockholders, and that the Company should act to assure such persons that there will be increased certainty
of protection in the future;

 

WHEREAS, it
is reasonable, prudent and necessary for the Company to contractually obligate itself to indemnify, and to advance expenses on
behalf of, such persons to the fullest extent permitted by applicable law so that they will serve or continue to serve the Company
free from undue concern that they will not be so indemnified;

 

WHEREAS, this
Agreement is a supplement to and in furtherance of the Bylaws and the Certificate of Incorporation and any resolutions adopted
pursuant thereto, and shall not be deemed a substitute therefor, nor to diminish or abrogate any rights of Indemnitee thereunder;

 

    

     

    

 

WHEREAS, Indemnitee
does not regard the protection available under the Bylaws and the Certificate of Incorporation and insurance as adequate in the
present circumstances, and may not be willing to serve as an officer or director without adequate protection, and the Company desires
Indemnitee to serve in such capacity. Indemnitee is willing to serve, continue to serve and to take on additional service for or
on behalf of the Company on the condition that he or she be so indemnified; and

 

WHEREAS, Indemnitee
has certain rights to indemnification and/or insurance provided by other entities or organizations which Indemnitee and such other
entities or organizations intend to be secondary to the primary obligation of the Company to indemnify Indemnitee as provided herein,
with the Company’s acknowledgement and agreement to the foregoing being a material condition to Indemnitee’s willingness
to serve on the Board.

 

NOW, THEREFORE,
in consideration of Indemnitee’s agreement to serve as a director from and after the date first written above, the parties
hereto agree as follows:

 

1.            
Indemnity of Indemnitee. The Company hereby agrees to hold harmless and indemnify Indemnitee to the fullest extent
permitted by law, as such may be amended from time to time. In furtherance of the foregoing indemnification, and without limiting
the generality thereof:

 

(a)              
Proceedings Other Than Proceedings by or in the Right of the Company. Indemnitee shall be entitled to the rights
of indemnification provided in this Section l(a) if, by reason of his or her Corporate Status (as hereinafter defined),
Indemnitee is, or is threatened to be made, a party to or participant in any Proceeding (as hereinafter defined) other than a Proceeding
by or in the right of the Company. Pursuant to this Section 1(a), Indemnitee shall be indemnified against all Expenses (as
hereinafter defined), judgments, penalties, fines and amounts paid in settlement actually and reasonably incurred by him or her,
or on his or her behalf, in connection with such Proceeding or any claim, issue or matter therein, if Indemnitee acted in good
faith and in a manner Indemnitee reasonably believed to be in or not opposed to the best interests of the Company, and with respect
to any criminal Proceeding, had no reasonable cause to believe Indemnitee’s conduct was unlawful.

 

(b)              
Proceedings by or in the Right of the Company. Indemnitee shall be entitled to the rights of indemnification provided
in this Section 1(b) if, by reason of his or her Corporate Status, Indemnitee is, or is threatened to be made, a party to
or participant in any Proceeding brought by or in the right of the Company. Pursuant to this Section 1(b), Indemnitee shall
be indemnified against all Expenses actually and reasonably incurred by Indemnitee, or on Indemnitee’s behalf, in connection
with such Proceeding if Indemnitee acted in good faith and in a manner Indemnitee reasonably believed to be in, or not opposed
to, the best interests of the Company; provided, however, if applicable law so provides, no indemnification against
such Expenses shall be made in respect of any claim, issue or matter in such Proceeding as to which Indemnitee shall have been
adjudged to be liable to the Company unless and to the extent that the Court of Chancery of the State of Delaware shall determine
that such indemnification may be made.

 

    2

     

    

 

(c)               Indemnification
for Expenses of a Party Who is Wholly or Partly Successful. Notwithstanding any other provision of this Agreement, to the
extent that Indemnitee is, by reason of his or her Corporate Status, a party to and is successful, on the merits or
otherwise, in any Proceeding, he or she shall be indemnified to the maximum extent permitted by law, as such may be amended
from time to time, against all Expenses actually and reasonably incurred by him or her or on his or her behalf in connection
therewith. If Indemnitee is not wholly successful in such Proceeding but is successful, on the merits or otherwise, as to one
or more but less than all claims, issues or matters in such Proceeding, the Company shall indemnify Indemnitee against all
Expenses actually and reasonably incurred by him or her or on his or her behalf in connection with each successfully resolved
claim, issue or matter. For purposes of this Section and without limitation, the termination of any claim, issue or matter in
such a Proceeding by dismissal, with or without prejudice, shall be deemed to be a successful result as to such claim, issue
or matter.

 

(d)              
Indemnification of Appointing Stockholder. If (i) Indemnitee is or was affiliated with one or more venture capital
funds that has invested in the Company (an “Appointing Stockholder”), (ii) the Appointing Stockholder is, or
is threatened to be made, a party to or a participant in any Proceeding, and (iii) the Appointing Stockholder’s involvement
in the Proceeding results from any claim based on Indemnitee’s service to the Company as a director or other fiduciary of
the Company, the Appointing Stockholder will be entitled to indemnification hereunder for Expenses to the same extent as Indemnitee,
and the terms of this Agreement as they relate to procedures for indemnification of Indemnitee and advancement of Expenses shall
apply to any such indemnification of Appointing Stockholder.

 

2.            
Additional Indemnity. In addition to, and without regard to any limitations on, the indemnification provided for
in Section 1 of this Agreement, the Company shall and hereby does indemnify and hold harmless Indemnitee against all Expenses,
judgments, penalties, fines and amounts paid in settlement actually and reasonably incurred by him or her or on his or her behalf
if, by reason of his or her Corporate Status, he or she is, or is threatened to be made, a party to or participant in any Proceeding
(including a Proceeding by or in the right of the Company), including, without limitation, any and all liability arising out of
the negligence or active or passive wrongdoing of Indemnitee. The only limitation that shall exist upon the Company’s obligations
pursuant to this Agreement shall be that the Company shall not be obligated to make any payment to Indemnitee that is finally determined
(under the procedures, and subject to the presumptions, set forth in Sections 6 and 7 hereof) to be unlawful.

 

3.             Contribution.

 

(a)              
Whether or not the indemnification provided in Sections 1 and 2 hereof is available, in respect of any threatened,
pending or completed action, suit or proceeding in which the Company is jointly liable with Indemnitee (or would be if joined in
such action, suit or proceeding), the Company shall pay, in the first instance, the entire amount of any judgment or settlement
of such action, suit or proceeding without requiring Indemnitee to contribute to such payment and the Company hereby waives and
relinquishes any right of contribution it may have against Indemnitee. The Company shall not enter into any settlement of any action,
suit or proceeding in which the Company is jointly liable with Indemnitee (or would be if joined in such action, suit or proceeding)
unless such settlement provides for a full and final release of all claims asserted against Indemnitee.

 

    3

     

    

 

(b)               Without
diminishing or impairing the obligations of the Company set forth in the preceding subparagraph, if, for any reason,
Indemnitee shall elect or be required to pay all or any portion of any judgment or settlement in any threatened, pending or
completed action, suit or proceeding in which the Company is jointly liable with Indemnitee (or would be if joined in such
action, suit or proceeding), the Company shall contribute to the amount of Expenses, judgments, fines and amounts paid in
settlement actually and reasonably incurred and paid or payable by Indemnitee in proportion to the relative benefits received
by the Company and all officers, directors or employees of the Company, other than Indemnitee, who are jointly liable with
Indemnitee (or would be if joined in such action, suit or proceeding), on the one hand, and Indemnitee, on the other hand,
from the transaction or events from which such action, suit or proceeding arose; provided, however, that the
proportion determined on the basis of relative benefit may, to the extent necessary to conform to law, be further adjusted by
reference to the relative fault of the Company and all officers, directors or employees of the Company other than Indemnitee
who are jointly liable with Indemnitee (or would be if joined in such action, suit or proceeding), on the one hand, and
Indemnitee, on the other hand, in connection with the transaction or events that resulted in such expenses, judgments, fines
or settlement amounts, as well as any other equitable considerations which applicable law may require to be considered. The
relative fault of the Company and all officers, directors or employees of the Company, other than Indemnitee, who are jointly
liable with Indemnitee (or would be if joined in such action, suit or proceeding), on the one hand, and Indemnitee, on the
other hand, shall be determined by reference to, among other things, the degree to which their actions were motivated by
intent to gain personal profit or advantage, the degree to which their liability is primary or secondary and the degree to
which their conduct is active or passive.

 

(c)              
The Company hereby agrees to fully indemnify and hold Indemnitee harmless from any claims of contribution which may be brought
by the officers, directors or employees of the Company, other than Indemnitee, who may be jointly liable with Indemnitee.

 

(d)              
To the fullest extent permissible under applicable law, if the indemnification provided for in this Agreement is unavailable
to Indemnitee for any reason whatsoever, the Company, in lieu of indemnifying Indemnitee, shall contribute to the amount incurred
by Indemnitee, whether for judgments, fines, penalties, excise taxes, amounts paid or to be paid in settlement and/or for Expenses,
in connection with any claim relating to an indemnifiable event under this Agreement, in such proportion as is deemed fair and
reasonable in light of all of the circumstances of such Proceeding in order to reflect (i) the relative benefits received by the
Company and Indemnitee as a result of the event(s) and/or transaction(s) giving cause to such Proceeding and/or (ii) the relative
fault of the Company (and its directors, officers, employees and agents) and Indemnitee in connection with such event(s) and/or
transaction(s).

 

4.             Indemnification for Expenses of a Witness. Notwithstanding any other provision of this Agreement, to the extent that
Indemnitee is, by reason of his or her Corporate Status, a witness, or is made (or asked) to respond to discovery requests, in
any Proceeding to which Indemnitee is not a party, he or she shall be indemnified against all Expenses actually and reasonably
incurred by him or her or on his or her behalf in connection therewith.

 

5.             Advancement
of Expenses. Notwithstanding any other provision of this Agreement, the Company shall advance all Expenses incurred by or
on behalf of Indemnitee in connection with any Proceeding by reason of Indemnitee’s Corporate Status within thirty (30)
days after the receipt by the Company of a statement or statements from Indemnitee requesting such advance or advances from
time to time, whether prior to or after final disposition of such Proceeding. Such statement or statements shall reasonably
evidence the Expenses incurred by Indemnitee and shall include or be preceded or accompanied by a written undertaking by or
on behalf of Indemnitee to repay any Expenses advanced if it shall ultimately be determined that Indemnitee is not entitled
to be indemnified against such Expenses. Any advances and undertakings to repay pursuant to this Section 5 shall be
unsecured and interest free.

 

    4

     

    

 

6.             Procedures and Presumptions for Determination of Entitlement to Indemnification. It is the intent of this Agreement
to secure for Indemnitee rights of indemnity that are as favorable as may be permitted under the DGCL and public policy of the
State of Delaware. Accordingly, the parties agree that the following procedures and presumptions shall apply in the event of any
question as to whether Indemnitee is entitled to indemnification under this Agreement:

 

(a)              
To obtain indemnification under this Agreement, Indemnitee shall submit to the Company a written request, including therein
or therewith such documentation and information as is reasonably available to Indemnitee and is reasonably necessary to determine
whether and to what extent Indemnitee is entitled to indemnification. The Secretary of the Company shall, promptly upon receipt
of such a request for indemnification, advise the Board in writing that Indemnitee has requested indemnification. Notwithstanding
the foregoing, any failure of Indemnitee to provide such a request to the Company, or to provide such a request in a timely fashion,
shall not relieve the Company of any liability that it may have to Indemnitee unless, and to the extent that, such failure actually
and materially prejudices the interests of the Company.

 

(b)              
Upon written request by Indemnitee for indemnification pursuant to the first sentence of Section 6(a) hereof, a determination
with respect to Indemnitee’s entitlement thereto shall be made in the specific case by one of the following four methods,
which shall be at the election of the Board (1) by a majority vote of the disinterested directors, even though less than a quorum,
(2) by a committee of disinterested directors designated by a majority vote of the disinterested directors, even though less than
a quorum, (3) if there are no disinterested directors or if the disinterested directors so direct, by independent legal counsel
in a written opinion to the Board, a copy of which shall be delivered to Indemnitee, or (4) if so directed by the Board, by the
stockholders of the Company. For purposes hereof, disinterested directors are those members of the Board who are not parties to
the action, suit or proceeding in respect of which indemnification is sought by Indemnitee.

 

(c)               If
the determination of entitlement to indemnification is to be made by Independent Counsel pursuant to Section 6(b) hereof,
the Independent Counsel shall be selected as provided in this Section 6(c). The Independent Counsel shall be selected
by the Board. Indemnitee may, within ten (10) days after such written notice of selection shall have been given, deliver to
the Company a written objection to such selection; provided, however, that such objection may be asserted only on the ground
that the Independent Counsel so selected does not meet the requirements of “Independent Counsel” as
defined in Section 13 of this Agreement, and the objection shall set forth with particularity the factual basis of
such assertion. Absent a proper and timely objection, the person so selected shall act as Independent Counsel. If a written
objection is made and substantiated, the Independent Counsel selected may not serve as Independent Counsel unless and until
such objection is withdrawn or a court has determined that such objection is without merit. If, within twenty (20) days after
submission by Indemnitee of a written request for indemnification pursuant to Section 6(a) hereof, no Independent
Counsel shall have been selected and not objected to, either the Company or Indemnitee may petition the Court of Chancery of
the State of Delaware or other court of competent jurisdiction for resolution of any objection which shall have been made by
Indemnitee to the Company’s selection of Independent Counsel and/or for the appointment as Independent Counsel of a
person selected by the court or by such other person as the court shall designate, and the person with respect to whom all
objections are so resolved or the person so appointed shall act as Independent Counsel under Section 6(b) hereof. The
Company shall pay any and all reasonable fees and expenses of Independent Counsel incurred by such Independent Counsel in
connection with acting pursuant to Section 6(b) hereof, and the Company shall pay all reasonable fees and expenses
incident to the procedures of this Section 6(c), regardless of the manner in which such Independent Counsel was
selected or appointed.

 

    5

     

    

 

(d)              
In making a determination with respect to entitlement to indemnification hereunder, the person or persons or entity making
such determination shall presume that Indemnitee is entitled to indemnification under this Agreement. Anyone seeking to overcome
this presumption shall have the burden of proof and the burden of persuasion by clear and convincing evidence. Neither the failure
of the Company (including by its directors or independent legal counsel) to have made a determination prior to the commencement
of any action pursuant to this Agreement that indemnification is proper in the circumstances because Indemnitee has met the applicable
standard of conduct, nor an actual determination by the Company (including by its directors or independent legal counsel) that
Indemnitee has not met such applicable standard of conduct, shall be a defense to the action or create a presumption that Indemnitee
has not met the applicable standard of conduct.

 

(e)              
Indemnitee shall be deemed to have acted in good faith if Indemnitee’s action is based on the records or books of
account of the Enterprise (as hereinafter defined), including financial statements, or on information supplied to Indemnitee by
the officers of the Enterprise in the course of their duties, or on the advice of legal counsel for the Enterprise or on information
or records given or reports made to the Enterprise by an independent certified public accountant or by an appraiser or other expert
selected with reasonable care by the Enterprise. In addition, the knowledge and/or actions, or failure to act, of any director,
officer, agent or employee of the Enterprise shall not be imputed to Indemnitee for purposes of determining the right to indemnification
under this Agreement. Whether or not the foregoing provisions of this Section 6(e) are satisfied, it shall in any event
be presumed that Indemnitee has at all times acted in good faith and in a manner he or she reasonably believed to be in or not
opposed to the best interests of the Company. Anyone seeking to overcome this presumption shall have the burden of proof and the
burden of persuasion by clear and convincing evidence.

 

(f)                If
the person, persons or entity empowered or selected under Section 6 to determine whether Indemnitee is entitled to
indemnification shall not have made a determination within sixty (60) days after receipt by the Company of the request
therefor, the requisite determination of entitlement to indemnification shall be deemed to have been made and Indemnitee
shall be entitled to such indemnification absent (i) a misstatement by Indemnitee of a material fact, or an omission of a
material fact necessary to make Indemnitee’s statement not materially misleading, in connection with the request for
indemnification, or (ii) a prohibition of such indemnification under applicable law; provided, however, that
such sixty (60) day period may be extended for a reasonable time, not to exceed an additional thirty (30) days, if the
person, persons or entity making such determination with respect to entitlement to indemnification in good faith requires
such additional time to obtain or evaluate documentation and/or information relating thereto; and provided further,
that the foregoing provisions of this Section 6(f) shall not apply if the determination of entitlement to
indemnification is to be made by the stockholders pursuant to Section 6(b) of this Agreement and if (A) within fifteen
(15) days after receipt by the Company of the request for such determination, the Board or the Disinterested Directors, if
appropriate, resolve to submit such determination to the stockholders for their consideration at an annual meeting thereof to
be held within seventy five (75) days after such receipt and such determination is made thereat, or (B) a special meeting of
stockholders is called within fifteen (15) days after such receipt for the purpose of making such determination, such meeting
is held for such purpose within sixty (60) days after having been so called and such determination is made thereat.

 

    6

     

    

 

(g)              
Indemnitee shall cooperate with the person, persons or entity making such determination with respect to Indemnitee’s
entitlement to indemnification, including providing to such person, persons or entity upon reasonable advance request any documentation
or information which is not privileged or otherwise protected from disclosure and which is reasonably available to Indemnitee and
reasonably necessary to such determination. Any Independent Counsel, member of the Board or stockholder of the Company shall act
reasonably and in good faith in making a determination regarding Indemnitee’s entitlement to indemnification under this Agreement.
Any costs or expenses (including attorneys’ fees and disbursements) incurred by Indemnitee in so cooperating with the person,
persons or entity making such determination shall be borne by the Company (irrespective of the determination as to Indemnitee’s
entitlement to indemnification) and the Company hereby indemnifies and agrees to hold Indemnitee harmless therefrom.

 

(h)              
The Company acknowledges that a settlement or other disposition short of final judgment may be successful if it permits
a party to avoid expense, delay, distraction, disruption and uncertainty. In the event that any action, claim or proceeding to
which Indemnitee is a party is resolved in any manner other than by adverse judgment against Indemnitee (including, without limitation,
settlement of such action, claim or proceeding with or without payment of money or other consideration) it shall be presumed that
Indemnitee has been successful on the merits or otherwise in such action, suit or proceeding. Anyone seeking to overcome this presumption
shall have the burden of proof and the burden of persuasion by clear and convincing evidence.

 

(i)               
The termination of any Proceeding or of any claim, issue or matter therein, by judgment, order, settlement or conviction,
or upon a plea of nolo contendere or its equivalent, shall not (except as otherwise expressly provided in this Agreement) of itself
adversely affect the right of Indemnitee to indemnification or create a presumption that Indemnitee did not act in good faith and
in a manner which he or she reasonably believed to be in or not opposed to the best interests of the Company or, with respect to
any criminal Proceeding, that Indemnitee had reasonable cause to believe that his or her conduct was unlawful.

 

7.             Remedies of Indemnitee.

 

(a)               In
the event that (i) a determination is made pursuant to Section 6 of this Agreement that Indemnitee is not entitled to
indemnification under this Agreement, (ii) advancement of Expenses is not timely made pursuant to Section 5 of this
Agreement, (iii) no determination of entitlement to indemnification is made pursuant to Section 6(b) of this Agreement
within ninety (90) days after receipt by the Company of the request for indemnification, (iv) payment of indemnification is
not made pursuant to this Agreement within ten (10) days after receipt by the Company of a written request therefor, or (v)
payment of indemnification is not made within ten (10) days after a determination has been made that Indemnitee is entitled
to indemnification or such determination is deemed to have been made pursuant to Section 6 of this Agreement,
Indemnitee shall be entitled to an adjudication in an appropriate court of the State of Delaware, or in any other court of
competent jurisdiction, of Indemnitee’s entitlement to such indemnification. Indemnitee shall commence such proceeding
seeking an adjudication within one hundred eighty (180) days following the date on which Indemnitee first has the right to
commence such proceeding pursuant to this Section 7(a). The Company shall not oppose Indemnitee’s right to seek
any such adjudication.

 

    7

     

    

 

(b)              
In the event that a determination shall have been made pursuant to Section 6(b) of this Agreement that Indemnitee
is not entitled to indemnification, any judicial proceeding commenced pursuant to this Section 7 shall be conducted in all
respects as a de novo trial on the merits, and Indemnitee shall not be prejudiced by reason of the adverse determination under
Section 6(b).

 

(c)              
If a determination shall have been made pursuant to Section 6(b) of this Agreement that Indemnitee is entitled to
indemnification, the Company shall be bound by such determination in any judicial proceeding commenced pursuant to this Section
7, absent (i) a misstatement by Indemnitee of a material fact, or an omission of a material fact necessary to make Indemnitee’s
misstatement not materially misleading in connection with the application for indemnification, or (ii) a prohibition of such indemnification
under applicable law.

 

(d)              
In the event that Indemnitee, pursuant to this Section 7, seeks a judicial adjudication of his or her rights under,
or to recover damages for breach of, this Agreement, or to recover under any directors’ and officers’ liability insurance
policies maintained by the Company, the Company shall pay on his or her behalf, in advance, any and all expenses (of the types
described in the definition of Expenses in Section 13 of this Agreement) actually and reasonably incurred by him or her
in such judicial adjudication, regardless of whether Indemnitee ultimately is determined to be entitled to such indemnification,
advancement of expenses or insurance recovery.

 

(e)              
The Company shall be precluded from asserting in any judicial proceeding commenced pursuant to this Section 7 that
the procedures and presumptions of this Agreement are not valid, binding and enforceable and shall stipulate in any such court
that the Company is bound by all the provisions of this Agreement. The Company shall indemnify Indemnitee against any and all Expenses
and, if requested by Indemnitee, shall (within ten (10) days after receipt by the Company of a written request therefore) advance,
to the extent not prohibited by law, such expenses to Indemnitee, which are incurred by Indemnitee in connection with any action
brought by Indemnitee for indemnification or advance of Expenses from the Company under this Agreement or under any directors'
and officers' liability insurance policies maintained by the Company, regardless of whether Indemnitee ultimately is determined
to be entitled to such indemnification, advancement of Expenses or insurance recovery, as the case may be.

 

(f)               
Notwithstanding anything in this Agreement to the contrary, no determination as to entitlement to indemnification under
this Agreement shall be required to be made prior to the final disposition of the Proceeding.

 

    8

     

    

 

8.              Non-Exclusivity; Survival of Rights; Insurance; Primacy of Indemnification; Subrogation.

 

(a)              
The rights of indemnification as provided by this Agreement shall not be deemed exclusive of any other rights to which Indemnitee
may at any time be entitled under applicable law, the Certificate of Incorporation, the By-laws, any agreement, a vote of stockholders,
a resolution of directors of the Company, or otherwise. No amendment, alteration or repeal of this Agreement or of any provision
hereof shall limit or restrict any right of Indemnitee under this Agreement in respect of any action taken or omitted by such Indemnitee
in his or her Corporate Status prior to such amendment, alteration or repeal. To the extent that a change in the DGCL, whether
by statute or judicial decision, permits greater indemnification than would be afforded currently under the Certificate of Incorporation,
By-laws and this Agreement, it is the intent of the parties hereto that Indemnitee shall enjoy by this Agreement the greater benefits
so afforded by such change. No right or remedy herein conferred is intended to be exclusive of any other right or remedy, and every
other right and remedy shall be cumulative and in addition to every other right and remedy given hereunder or now or hereafter
existing at law or in equity or otherwise. The assertion or employment of any right or remedy hereunder, or otherwise, shall not
prevent the concurrent assertion or employment of any other right or remedy.

 

(b)              
To the extent that the Company maintains an insurance policy or policies providing liability insurance for directors, officers,
employees, agents or fiduciaries of the Company or of any other corporation, partnership, joint venture, trust, employee benefit
plan or other enterprise that such person serves at the request of the Company, Indemnitee shall be covered by such policy or policies
in accordance with its or their terms to the maximum extent of the coverage available for any director, officer, employee, agent
or fiduciary under such policy or policies. If, at the time of the receipt of a notice of a claim pursuant to the terms hereof,
the Company has directors' and officers' liability insurance in effect, the Company shall give prompt notice of the commencement
of such proceeding to the insurers in accordance with the procedures set forth in the respective policies. The Company shall thereafter
take all necessary or desirable action to cause such insurers to pay, on behalf of Indemnitee, all amounts payable as a result
of such proceeding in accordance with the terms of such policies.

 

(c)               
The Company hereby acknowledges that Indemnitee has certain rights to indemnification, advancement of expenses and/or
insurance provided by other entities or organizations (collectively, the “Fund Indemnitors”). The Company hereby
agrees that (i) it is the indemnitor of first resort (i.e., its obligations to Indemnitee are primary and any
obligation of the Fund Indemnitors to advance expenses or to provide indemnification for the same expenses or liabilities
incurred by Indemnitee are secondary), (ii) it shall be required to advance the full amount of expenses incurred by
Indemnitee and shall be liable for the full amount of all Expenses, judgments, penalties, fines and amounts paid in
settlement to the extent legally permitted and as required by the terms of this Agreement and the Certificate of
Incorporation or Bylaws of the Company (or any other agreement between the Company and Indemnitee), without regard to any
rights Indemnitee may have against the Fund Indemnitors, and (iii) it irrevocably waives, relinquishes and releases the Fund
Indemnitors from any and all claims against the Fund Indemnitors for contribution, subrogation or any other recovery of any
kind in respect thereof. The Company further agrees that no advancement or payment by the Fund Indemnitors on behalf of
Indemnitee with respect to any claim for which Indemnitee has sought indemnification from the Company shall affect the
foregoing and the Fund Indemnitors shall have a right of contribution and/or be subrogated to the extent of such advancement
or payment to all of the rights of recovery of Indemnitee against the Company. The Company and Indemnitee agree that the Fund
Indemnitors are express third party beneficiaries of the terms of this Section 8(c).

 

    9

     

    

 

(d)              
Except as provided in paragraph (c) above, in the event of any payment under this Agreement, the Company shall be subrogated
to the extent of such payment to all of the rights of recovery of Indemnitee (other than against the Fund Indemnitors), who shall
execute all papers required and take all action necessary to secure such rights, including execution of such documents as are necessary
to enable the Company to bring suit to enforce such rights.

 

(e)              
Except as provided in paragraph (c) above, the Company shall not be liable under this Agreement to make any payment of amounts
otherwise indemnifiable hereunder if and to the extent that Indemnitee has otherwise actually received such payment under any insurance
policy, contract, agreement or otherwise.

 

(f)               
Except as provided in paragraph (c) above, the Company's obligation to indemnify or advance Expenses hereunder to Indemnitee
who is or was serving at the request of the Company as a director, officer, employee or agent of any other corporation, partnership,
joint venture, trust, employee benefit plan or other enterprise shall be reduced by any amount Indemnitee has actually received
as indemnification or advancement of expenses from such other corporation, partnership, joint venture, trust, employee benefit
plan or other enterprise.

 

9.              Exception to Right of Indemnification. Notwithstanding any provision in this Agreement, the Company shall not be
obligated under this Agreement to make any indemnity in connection with any claim made against Indemnitee:

 

(a)              
for which payment has actually been made to or on behalf of Indemnitee under any insurance policy or other indemnity provision,
except with respect to any excess beyond the amount paid under any insurance policy or other indemnity provision, provided, that
the foregoing shall not affect the rights of Indemnitee or the Fund Indemnitors set forth in Section 8(c) above;

 

(b)              
for an accounting of profits made from the purchase and sale (or sale and purchase) by Indemnitee of securities of the Company
within the meaning of Section 16(b) of the Exchange Act, or similar provisions of state statutory law or common law; or

 

(c)              
in connection with any Proceeding (or any part of any Proceeding) initiated by Indemnitee, including any Proceeding (or
any part of any Proceeding) initiated by Indemnitee against the Company or its directors, officers, employees or other indemnitees,
unless (i) the Board authorized the Proceeding (or any part of any Proceeding) prior to its initiation, or (ii) the Company provides
the indemnification, in its sole discretion, pursuant to the powers vested in the Company under applicable law;

 

(d)              
with respect to remuneration paid to Indemnitee if it is determined by final judgment or other final adjudication that such
remuneration was in violation of law (and in this respect, both the Company and Indemnitee have been advised that the SEC believes
that indemnification for liabilities arising under the federal securities laws is against public policy and is therefore unenforceable
and that claims for indemnification should be submitted to appropriate courts for adjudication, as indicated in the last paragraph
of this Section 9);

 

    10

     

    

 

(e)              
 a final judgment or other final adjudication is made that Indemnitee’s conduct was in bad faith, knowingly fraudulent
or deliberately dishonest or constituted willful misconduct (but only to the extent of such specific determination);

 

(f)               
in connection with any claim for reimbursement or any recovery policy of the Company by Indemnitee of any bonus or other
incentive-based or equity-based compensation or of any profits realized by Indemnitee from the sale of securities of the Company,
as required in each case under the Exchange Act (including any such reimbursements that arise from an accounting restatement of
the Company pursuant to Section 304 of the Sarbanes-Oxley Act or Section 954 of the Dodd-Frank Act, or the payment to the Company
of profits arising from the purchase and sale by Indemnitee of securities in violation of Section 306 of the Sarbanes Oxley Act),
if Indemnitee is held liable therefor (including pursuant to any settlement); or

 

(g)              
on account of conduct that is established by a final judgement as constituted a breach of Indemnitee’s duty of loyalty
to the Company or resulting in any personal profit or advantage to which Indemnitee is not legally entitled.

 

For purposes of this
Section 9, a final judgment or other adjudication may be reached in either the underlying proceeding or action in connection with
which indemnification is sought or a separate proceeding or action to establish rights and liabilities under this Agreement.

 

10.           Duration of Agreement. All agreements and obligations of the Company contained herein shall continue during the period
Indemnitee is an officer or director of the Company (or is or was serving at the request of the Company as a director, officer,
employee or agent of another corporation, partnership, joint venture, trust or other enterprise) and shall continue thereafter
so long as Indemnitee shall be subject to any Proceeding (or any proceeding commenced under Section 7 hereof) by reason
of his or her Corporate Status, whether or not he or she is acting or serving in any such capacity at the time any liability or
expense is incurred for which indemnification can be provided under this Agreement. This Agreement shall be binding upon and inure
to the benefit of and be enforceable by the parties hereto and their respective successors (including any direct or indirect successor
by purchase, merger, consolidation or otherwise to all or substantially all of the business or assets of the Company), assigns,
spouses, heirs, executors and personal and legal representatives.

 

11.           Security. To the extent requested by Indemnitee and approved by the Board, the Company may at any time and from time
to time provide security to Indemnitee for the Company’s obligations hereunder through an irrevocable bank line of credit,
funded trust or other collateral. Any such security, once provided to Indemnitee, may not be revoked or released without the prior
written consent of Indemnitee.

 

12.           Enforcement.

 

(a)              
The Company expressly confirms and agrees that it has entered into this Agreement and assumes the obligations imposed on
it hereby in order to induce Indemnitee to serve as an officer or director of the Company, and the Company acknowledges that Indemnitee
is relying upon this Agreement in serving as an officer or director of the Company.

 

(b)               This
Agreement constitutes the entire agreement between the parties hereto with respect to the subject matter hereof and
supersedes all prior agreements and understandings, oral, written and implied, between the parties hereto with respect to the
subject matter hereof.

 

    11

     

    

 

(c)              
The Company shall not seek from a court, or agree to, a "bar order" which would have the effect of prohibiting
or limiting Indemnitee's rights to receive advancement of expenses under this Agreement.

 

13.           Definitions. For purposes of this Agreement:

 

(a)              
“Corporate Status” describes the status of a person who is or was a director, officer, employee, agent
or fiduciary of the Company or of any other corporation, partnership, joint venture, trust, employee benefit plan or other enterprise
that such person is or was serving at the express written request of the Company.

 

(b)              
“Disinterested Director” means a director of the Company who is not and was not a party to the Proceeding
in respect of which indemnification is sought by Indemnitee.

 

(c)              
“Dodd-Frank Act” means the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010.

 

(d)              
“Enterprise” shall mean the Company and any other corporation, partnership, joint venture, trust, employee
benefit plan or other enterprise that Indemnitee is or was serving at the express written request of the Company as a director,
officer, employee, agent or fiduciary.

 

(e)              
“Exchange Act” means the Securities Exchange Act of 1934, as amended.

 

(f)               
“Expenses” shall include all reasonable attorneys’ fees, retainers, court costs, transcript costs,
fees of experts, witness fees, travel expenses, duplicating costs, printing and binding costs, telephone charges, postage, delivery
service fees and all other disbursements or expenses of the types customarily incurred in connection with prosecuting, defending,
preparing to prosecute or defend, investigating, participating, or being or preparing to be a witness in a Proceeding, or responding
to, or objecting to, a request to provide discovery in any Proceeding. Expenses also shall include Expenses incurred in connection
with any appeal resulting from any Proceeding, and any federal, state, local or foreign taxes imposed on Indemnitee as a result
of the actual or deemed receipt of any payments under this Agreement, including without limitation the premium, security for, and
other costs relating to any cost bond, supersede as bond, or other appeal bond or its equivalent. Expenses, however, shall not
include amounts paid in settlement by Indemnitee or the amount of judgments or fines against Indemnitee.

 

(g)               “Independent
Counsel” means a law firm, or a member of a law firm, that is experienced in matters of corporation law and neither
presently is, nor in the past five years has been, retained to represent (i) the Company or Indemnitee in any matter material
to either such party (other than with respect to matters concerning Indemnitee under this Agreement, or of other indemnitees
under similar indemnification agreements), or (ii) any other party to the Proceeding giving rise to a claim for
indemnification hereunder. Notwithstanding the foregoing, the term “Independent Counsel” shall not include any
person who, under the applicable standards of professional conduct then prevailing, would have a conflict of interest in
representing either the Company or Indemnitee in an action to determine Indemnitee’s rights under this Agreement. The
Company agrees to pay the reasonable fees of the Independent Counsel referred to above and to fully indemnify such counsel
against any and all Expenses, claims, liabilities and damages arising out of or relating to this Agreement or its engagement
pursuant hereto.

 

    12

     

    

 

(h)              
“Proceeding” includes any threatened, pending or completed action, suit, arbitration, alternate dispute
resolution mechanism, investigation, inquiry, administrative hearing or any other actual, threatened or completed proceeding, whether
brought by or in the right of the Company or otherwise and whether civil, criminal, administrative or investigative, in which Indemnitee
was, is or will be involved as a party or otherwise, by reason of his or her Corporate Status, by reason of any action taken by
him or of any inaction on his or her part while acting in his or her Corporate Status; in each case whether or not he or she is
acting or serving in any such capacity at the time any liability or expense is incurred for which indemnification can be provided
under this Agreement; including one pending on or before the date of this Agreement, but excluding one initiated by an Indemnitee
pursuant to Section 7 of this Agreement to enforce his or her rights under this Agreement.

 

(i)                
“Sarbanes-Oxley Act” means the Sarbanes-Oxley Act of 2002, as amended.

 

(j)                
“SEC” means the Securities and Exchange Commission.

 

14.           Severability. The invalidity or unenforceability of any provision hereof shall in no way affect the validity or enforceability
of any other provision. Further, the invalidity or unenforceability of any provision hereof as to either Indemnitee or Appointing
Stockholder shall in no way affect the validity or enforceability of any provision hereof as to the other. Without limiting the
generality of the foregoing, this Agreement is intended to confer upon Indemnitee and Appointing Stockholder indemnification rights
to the fullest extent permitted by applicable laws. In the event any provision hereof conflicts with any applicable law, such provision
shall be deemed modified, consistent with the aforementioned intent, to the extent necessary to resolve such conflict.

 

15.           Modification and Waiver. No supplement, modification, termination or amendment of this Agreement shall be binding
unless executed in writing by both of the parties hereto. No waiver of any of the provisions of this Agreement shall be deemed
or shall constitute a waiver of any other provisions hereof (whether or not similar) nor shall such waiver constitute a continuing
waiver.

 

16.           Notice By Indemnitee. Indemnitee agrees promptly to notify the Company in writing upon being served with or otherwise
receiving any summons, citation, subpoena, complaint, indictment, information or other document relating to any Proceeding or matter
which may be subject to indemnification covered hereunder. The failure to so notify the Company shall not relieve the Company of
any obligation which it may have to Indemnitee under this Agreement or otherwise unless and only to the extent that such failure
or delay materially prejudices the Company.

 

    13

     

    

 

17.           Notices. All notices and other communications given or made pursuant to this Agreement shall be in writing and shall
be deemed effectively given (a) upon personal delivery to the party to be notified, (b) when sent by confirmed electronic mail
or facsimile if sent during normal business hours of the recipient, and if not so confirmed, then on the next business day, (c)
five (5) days after having been sent by registered or certified mail, return receipt requested, postage prepaid, or (d) one (1)
day after deposit with a nationally recognized overnight courier, specifying next day delivery, with written verification of receipt.
All communications shall be sent:

 

(a)              
To Indemnitee at the address set forth below Indemnitee signature hereto.

 

(b)              
To the Company at:

 

      Immunome, Inc.

      665 Stockton Drive – Suite 300

      Exton, PA 19341

 

or to such other address
as may have been furnished to Indemnitee by the Company or to the Company by Indemnitee, as the case may be.

 

18.             
Counterparts. This Agreement may be executed in two (2) or more counterparts, each of which shall be deemed an original,
but all of which together shall constitute one and the same the same instrument. Counterparts may be delivered via facsimile, electronic
mail (including pdf or any electronic signature complying with the U.S. federal ESIGN Act of 2000, e.g., www.docusign.com)
or other transmission method and any counterpart so delivered shall be deemed to have been duly and validly delivered and be valid
and effective for all purposes.

 

19.             
Headings. The headings of the paragraphs of this Agreement are inserted for convenience only and shall not be deemed
to constitute part of this Agreement or to affect the construction thereof.

 

20.             
Governing Law and Consent to Jurisdiction. This Agreement and the legal relations among the parties shall be governed
by, and construed and enforced in accordance with, the laws of the State of Delaware, without regard to its conflict of laws rules.
The Company and Indemnitee hereby irrevocably and unconditionally (i) agree that any action or proceeding arising out of or in
connection with this Agreement shall be brought only in the Chancery Court of the State of Delaware (the “Delaware Court”),
and not in any other state or federal court in the United States of America or any court in any other country, (ii) consent to
submit to the exclusive jurisdiction of the Delaware Court for purposes of any action or proceeding arising out of or in connection
with this Agreement, (iii) waive any objection to the laying of venue of any such action or proceeding in the Delaware Court, and
(iv) waive, and agree not to plead or to make, any claim that any such action or proceeding brought in the Delaware Court has been
brought in an improper or inconvenient forum.

 

SIGNATURE PAGE TO FOLLOW

 

    14

     

    

 

IN WITNESS WHEREOF, the parties hereto have
executed this Indemnification Agreement on and as of the day and year first above written.

 

	 	 	IMMUNOME, INC.
	 	 	 	 
	 	 	By:	                
	 	 	Name:  	 
	 	 	Title:	 
	 	 	 	 
	 	 	INDEMNITEE
	 	 	 	 
	 	 	 	 
	 	 	Name:	 
	 	 	 	 
	 	Address:  	 	 
	 	 	 	 
	 	 	 	 
	 	 	 	 

 

    15Exhibit 10.2

 

Effective Date: July
3, 2008

Amended or Amended
and Restated: April 8, 2010, November 17, 2015, July 1, 2016 and January 17, 2017

 

IMMUNOME,
INC.

 

AMENDED
AND RESTATED

2008
EQUITY INCENTIVE PLAN

 

The purpose of the
Immunome, Inc. Amended and Restated 2008 Equity Incentive Plan is to provide (i) designated employees of Immunome, Inc. (the “Company”)
and its parents and subsidiaries, (ii) certain consultants and advisors who perform services for the Company or its parents or
subsidiaries and (iii) non-employee members of the Board of Directors of the Company (the “Board”) with the opportunity
to receive grants of incentive stock options, nonqualified stock options and stock awards. The Company believes that the Plan will
encourage the participants to contribute materially to the growth of the Company, thereby benefitting the Company’s stockholders,
and will align the economic interests of the participants with those of the stockholders.

 

1.                 
Administration.

 

(a)              
Committee. This Plan shall be administered and interpreted by the Board or by a committee consisting of members
of the Board, which shall be appointed by the Board. After an initial public offering of the Company’s stock as described
in Section 18(b) (a “Public Offering”), this Plan shall be administered by a committee of Board members, which may
consist of “outside directors” as defined under section 162(m) of the Internal Revenue Code of 1986, as amended (the
 “Code”), and related Treasury regulations, and “non-employee directors” as defined under Rule 16b-3 under
the Securities Exchange Act of 1934, as amended (the “Exchange Act”). However, the Board may ratify or approve any
grants as it deems appropriate, and the Board shall approve and administer all grants made to non-employee directors. The committee
may delegate authority to one or more subcommittees as it deems appropriate. To the extent that a committee or subcommittee administers
this Plan, references in this Plan to the “Board” shall be deemed to refer to the committee or subcommittee.

 

(b)             
Board Authority. The Board shall have the sole authority to determine the individuals to whom grants shall be
made under this Plan, determine the type, size and terms of the grants to be made to each such individual, determine the time when
the grants will be made and the duration of any applicable exercise or restriction period, including the criteria for exercisability
and the acceleration of exercisability, amend the terms of any previously issued grant, and deal with any other matters arising
under this Plan.

 

(c)               Board
Determinations. The Board shall have full power and authority to administer and interpret this Plan, to make factual
determinations and to adopt or amend such rules, regulations, agreements and instruments for implementing this Plan and for
the conduct of its business as it deems necessary or advisable, in its sole discretion. The Board’s interpretations of
this Plan and all determinations made by the Board pursuant to the powers vested in it hereunder shall be conclusive and
binding on all persons having any interest in this Plan or in any awards granted hereunder. All powers of the Board shall be
executed in its sole discretion, in the best interest of the Company, not as a fiduciary, and in keeping with the objectives
of this Plan and need not be uniform as to similarly situated individuals.

 

    1

     

    

 

(d)             
Delegation to Officers. To the extent permitted by applicable law, the Board may delegate to one or more officers
of the Company the power to grant Options (as defined in Section 2 below) to employees or officers of the Company or any of its
present or future subsidiary corporations and to exercise such other powers under this Plan as the Board may determine, provided
that the Board shall fix the terms of the Options to be granted by such officers (including the exercise price of such Options,
which may include a formula by which the exercise price will be determined) and the maximum number of shares subject to Options
that the officers may grant; provided further, however, that no officer shall be authorized to grant Options to himself or herself.

 

2.                 
Grants. Awards under this Plan may consist of grants of incentive stock options as described in Section 5 (“Incentive
Stock Options”), nonqualified stock options as described in Section 5 (“Nonqualified Stock Options”) (Incentive
Stock Options and Nonqualified Stock Options are collectively referred to as “Options”) and stock awards as described
in Section 6 (“Stock Awards”) (hereinafter collectively referred to as “Grants”). All Grants shall be subject
to the terms and conditions set forth herein and to such other terms and conditions consistent with this Plan as the Board deems
appropriate and as are specified in writing by the Board to the individual in a grant instrument or an amendment to the grant instrument
(the “Grant Instrument”). All Grants shall be made conditional upon the Grantee’s acknowledgement, in writing
or by acceptance of the Grant, that all decisions and determinations of the Board shall be final and binding on the Grantee, his
or her beneficiaries and any other person having or claiming an interest under such Grant. The Board shall approve the form and
provisions of each Grant Instrument. Grants under a particular Section of this Plan need not be uniform as among the grantees.

 

3.                 
Shares Subject to This Plan.

 

(a)              
Shares Authorized. Subject to adjustment as described below, the aggregate number of shares of common stock of
the Company (“Company Stock”) that may be issued under this Plan is 5,684,560 shares, all of which may be granted as
Incentive Stock Options. After a Public Offering, the maximum aggregate number of shares of Company Stock that shall be subject
to Grants made under this Plan to any individual during any calendar year shall be 1,500,000 shares, subject to adjustment as described
below. Shares issued under this Plan may be authorized but unissued shares of Company Stock or reacquired shares of Company Stock,
including shares purchased by the Company on the open market for purposes of this Plan. If and to the extent Options granted under
this Plan terminate, expire, or are canceled, forfeited, exchanged or surrendered without having been exercised or if any Stock
Awards (including restricted Stock Awards received upon the exercise of Options) are forfeited, the shares subject to such Grants
shall again be available for purposes of this Plan.

 

(b)              Adjustments.
In the event of any change in the number or kind of shares of Company Stock outstanding by reason of a stock dividend,
spinoff, recapitalization, stock split, or combination or exchange of shares, by reason of a merger, reorganization or
consolidation, by reason of a reclassification or change in par value, or by reason of any other extraordinary or unusual
event affecting the outstanding Company Stock as a class without the Company’s receipt of consideration, or if the
value of outstanding shares of Company Stock is substantially reduced as a result of a spinoff or the Company’s payment
of an extraordinary dividend or distribution, the maximum number of shares of Company Stock available for Grants, the maximum
number of shares of Company Stock that any individual participating in this Plan may be granted in any year, the number of
shares covered by outstanding Grants, the kind of shares issued under this Plan, and the price per share of such Grants may
be appropriately adjusted by the Board to reflect any increase or decrease in the number of, or change in the kind or value
of, issued shares of Company Stock to preclude, to the extent practicable, the enlargement or dilution of rights and benefits
under such Grants; provided, however, that any fractional shares resulting from such adjustment shall be eliminated. Any
adjustments determined by the Board shall be final, binding and conclusive.

 

4.                 
Eligibility for Participation.

 

(a)              
Eligible Persons. All employees of the Company and its parents or subsidiaries (“Employees”), including
Employees who are officers or members of the Board, and members of the Board who are not Employees (“Non-Employee Directors”)
shall be eligible to participate in this Plan. Consultants and advisors who perform services for the Company or any of its parents
or subsidiaries (“Key Advisors”) shall be eligible to participate in this Plan if the Key Advisors render bona fide
services to the Company or its parents or subsidiaries, the services are not in connection with the offer and sale of securities
in a capital-raising transaction, and the Key Advisors do not directly or indirectly promote or maintain a market for the Company’s
securities.

 

    2

     

    

 

(b)             
Selection of Grantees. The Board shall select the Employees, Non-Employee Directors and Key Advisors to receive
Grants and shall determine the number of shares of Company Stock subject to a particular Grant in such manner as the Board determines.
Employees, Key Advisors and Non-Employee Directors who receive Grants under this Plan shall hereinafter be referred to as “Grantees.”

 

5.                 
Granting of Options.

 

(a)              
Number of Shares. The Board shall determine the number of shares of Company Stock that will be subject to each
Grant of Options to Employees, Non-Employee Directors and Key Advisors.

 

(b)             
Type of Option and Price.

 

(i)                
The Board may grant Incentive Stock Options that are intended to qualify as “incentive stock options” within
the meaning of section 422 of the Code or Nonqualified Stock Options that are not intended so to qualify or any combination of
Incentive Stock Options and Nonqualified Stock Options, all in accordance with the terms and conditions set forth herein. Incentive
Stock Options may be granted only to employees of the Company or its parents or subsidiaries, as defined in Section 424 of the
Code. Nonqualified Stock Options may be granted to Employees, Non-Employee Directors and Key Advisors.

 

(ii)              The
purchase price (the “Exercise Price”) of Company Stock subject to an Option shall be determined by the Board and
may be equal to or greater than the Fair Market Value (as defined below) of a share of Company Stock on the date the Option
is granted; provided, however, that (A) the Exercise Price of an Incentive Stock Option shall be equal to, or greater than,
the Fair Market Value of a share of Company Stock on the date the Incentive Stock Option is granted and (B) an Incentive
Stock Option may not be granted to an Employee who, at the time of grant, owns stock possessing more than 10% of the total
combined voting power of all classes of stock of the Company or any parent or subsidiary of the Company, unless the Exercise
Price per share is not less than 110% of the Fair Market Value of Company Stock on the date of grant.

 

(iii)           
If the Company Stock is publicly traded, then the Fair Market Value per share shall be determined as follows: (A) if the
principal trading market for the Company Stock is a national securities exchange or the Nasdaq National Market, the last reported
sale price thereof on the relevant date or (if there were no trades on that date) the latest preceding date upon which a sale was
reported, or (B) if the Company Stock is not principally traded on such exchange or market, the mean between the last reported
 “bid” and “asked” prices of Company Stock on the relevant date, as reported on Nasdaq or, if not so reported,
as reported by the National Daily Quotation Bureau, Inc. or as reported in a customary financial reporting service, as applicable
and as the Board determines. If the Company Stock is not publicly traded or, if publicly traded, is not subject to reported transactions
or “bid” or “asked” quotations as set forth above, the Fair Market Value per share shall be as determined
by the Board.

 

(c)              
Option Term. The Board shall determine the term of each Option. The term of any Option shall not exceed ten years
from the date of grant. However, an Incentive Stock Option that is granted to an Employee who, at the time of grant, owns stock
possessing more than 10% of the total combined voting power of all classes of stock of the Company, or any parent or subsidiary
of the Company, may not have a term that exceeds five years from the date of grant.

 

(d)             
Exercisability of Options.

 

(i)                
Options shall become exercisable in accordance with such terms and conditions, consistent with this Plan, as may be determined
by the Board and specified in the Grant Instrument. The Board may accelerate the exercisability of any or all outstanding Options
at any time for any reason.

 

(ii)             
The Board may provide in a Grant Instrument that the Grantee may elect to exercise part or all of an Option before it otherwise
has become exercisable. Any shares so purchased shall be restricted shares and shall be subject to a repurchase right in favor
of the Company during a specified restriction period, with the repurchase price equal to the lesser of (A) the Exercise Price or
(B) the Fair Market Value of such shares at the time of repurchase, or such other restrictions as the Board deems appropriate.

 

    3

     

    

 

(e)              
Grants to Non-Exempt Employees. Notwithstanding the foregoing, Options granted to persons who are non-exempt
employees under the Fair Labor Standards Act of 1938, as amended, shall have an Exercise Price not less than the Fair Market Value
of the Company Stock on the date of grant, and may not be exercisable for at least six months after the date of grant (except that
such Options may become exercisable, as determined by the Board, upon the Grantee’s death, Disability or retirement, or upon
a Change of Control or other circumstances permitted by applicable regulations).

 

(f)               
 Termination of Employment, Disability or Death.

 

(i)                
Except as provided below, an Option may only be exercised while the Grantee is employed by, or providing service to, the
Employer (as defined below) as an Employee, Key Advisor or member of the Board. In the event that a Grantee ceases to be employed
by, or provide service to, the Employer for any reason other than Disability, death, or termination for Cause, any Option which
is otherwise exercisable by the Grantee shall terminate unless exercised within 90 days after the date on which the Grantee ceases
to be employed by, or provide service to, the Employer (or within such other period of time as may be specified by the Board),
but in any event no later than the date of expiration of the Option term. Except as otherwise provided by the Board, any of the
Grantee’s Options that are not otherwise exercisable as of the date on which the Grantee ceases to be employed by, or provide
service to, the Employer shall terminate as of such date.

 

(ii)             
In the event the Grantee ceases to be employed by, or provide service to, the Employer on account of a termination for Cause
by the Employer, any Option held by the Grantee shall terminate as of the date the Grantee ceases to be employed by, or provide
service to, the Employer. In addition, notwithstanding any other provisions of this Section 5, if the Board determines that the
Grantee has engaged in conduct that constitutes Cause at any time while the Grantee is employed by, or providing service to, the
Employer or after the Grantee’s termination of employment or service, any Option held by the Grantee shall immediately terminate,
and the Grantee shall automatically forfeit all shares underlying any exercised portion of an Option for which the Company has
not yet delivered the share certificates, upon refund by the Company of the Exercise Price paid by the Grantee for such shares.
Upon any exercise of an Option, the Company may withhold delivery of share certificates pending resolution of an inquiry that could
lead to a finding resulting in a forfeiture.

 

(iii)           
In the event the Grantee ceases to be employed by, or provide service to, the Employer because the Grantee is Disabled,
any Option which is otherwise exercisable by the Grantee shall terminate unless exercised within one year after the date on which
the Grantee ceases to be employed by, or provide service to, the Employer (or within such other period of time as may be specified
by the Board), but in any event no later than the date of expiration of the Option term. Except as otherwise provided by the Board,
any of the Grantee’s Options which are not otherwise exercisable as of the date on which the Grantee ceases to be employed
by, or provide service to, the Employer shall terminate as of such date.

 

(iv)            
If the Grantee dies while employed by, or providing service to, the Employer or within 90 days after the date on which the
Grantee ceases to be employed or provide service on account of a termination specified in Section 5(f)(i) above (or within such
other period of time as may be specified by the Board), any Option that is otherwise exercisable by the Grantee shall terminate
unless exercised within one year after the date on which the Grantee ceases to be employed by, or provide service to, the Employer
(or within such other period of time as may be specified by the Board), but in any event no later than the date of expiration of
the Option term. Except as otherwise provided by the Board, any of the Grantee’s Options that are not otherwise exercisable
as of the date on which the Grantee ceases to be employed by, or provide service to, the Employer shall terminate as of such date.

 

(v)              
 For purposes of this Section 5(f) and Section 6:

 

1.                 
The term “Employer” shall include the Company and its parent and subsidiary corporations or other entities,
as appropriate and as determined by the Board.

 

2.                 
“Employed by, or provide service to, the Employer” shall mean employment or service as an Employee, Key Advisor
or member of the Board (so that, for purposes of exercising Options and satisfying conditions with respect to Stock Awards, a Grantee
shall not be considered to have terminated employment or service until the Grantee ceases to be an Employee, Key Advisor or member
of the Board), unless the Board determines otherwise.

 

3.                 
“Disability” shall mean a Grantee’s becoming disabled within the meaning of section 22(e)(3) of the Code,
within the meaning of the Employer’s long-term disability plan applicable to the Grantee, or as otherwise determined by the
Board.

 

    4

     

    

 

4.                 
“Cause” shall mean, except to the extent specified otherwise by the Board, a finding by the Board that the Grantee
has breached his or her employment or service contract with the Employer, has engaged in disloyalty to the Company, including,
without limitation, fraud, embezzlement, theft, commission of a felony or proven dishonesty, has disclosed trade secrets or confidential
information of the Employer to persons not entitled to receive such information, has breached any written noncompetition or nonsolicitation
agreement between the Grantee and the Employer or has engaged in such other behavior detrimental to the interests of the Employer
as the Board determines.

 

(g)              
Exercise of Options. A Grantee may exercise an Option that has become exercisable, in whole or in part, by delivering
a notice of exercise to the Company with payment of the Exercise Price; provided, however, that the Committee shall have the power
to permit: (i) the exercise of unvested Options, or portions thereof, for the purchase of shares of restricted Common Stock subject
to a repurchase right in favor of the Company, with a repurchase price being equal to the lesser of (x) the original purchase price
or (y) the Fair Market Value of the shares on the date of repurchase, or to any other restrictions as the Committee deems to be
appropriate, and (ii) the acceleration of previously established exercise terms, in each case upon such circumstances and subject
to such terms and conditions as the Committee shall determine. The Grantee shall pay the Exercise Price for an Option as specified
by the Board (I) in cash, (II) with the approval of the Board, by delivering shares of Company Stock owned by the Grantee (including
Company Stock acquired or issuable in connection with the exercise of an Option, subject to such restrictions as the Board deems
appropriate) and having a Fair Market Value on the date of exercise equal to the Exercise Price or by attestation (on a form prescribed
by the Board) to ownership of shares of Company Stock having a Fair Market Value on the date of exercise equal to the Exercise
Price, (III) after a Public Offering, payment through a broker in accordance with procedures permitted by Regulation T of the Federal
Reserve Board, or (IV) by such other method as the Board may approve. The Board may authorize loans by the Company to Grantees
in connection with the exercise of an Option, upon such terms and conditions as the Board, in its sole discretion, deems appropriate.
Shares of Company Stock used to exercise an Option shall have been held by the Grantee for the requisite period of time to avoid
adverse accounting consequences to the Company with respect to the Option. The Grantee shall pay the Exercise Price and the amount
of any withholding tax due (pursuant to Section 7) at the time of exercise.

 

(h)             
 Limits on Incentive Stock Options. Each Incentive Stock Option shall provide that, if the aggregate Fair Market
Value of the stock on the date of the grant with respect to which Incentive Stock Options are exercisable for the first time by
a Grantee during any calendar year, under this Plan or any other stock option plan of the Company or a parent or subsidiary, exceeds
$100,000, then the Option, as to the excess, shall be treated as a Nonqualified Stock Option. An Incentive Stock Option shall not
be granted to any person who is not an Employee of the Company or a parent or subsidiary (within the meaning of section 424(f)
of the Code) of the Company.

 

6.                 
Stock Awards. The Board may issue shares of Company Stock to an Employee, Non-Employee Director or Key Advisor
under a Stock Award, upon such terms as the Board deems appropriate. The following provisions are applicable to Stock Awards:

 

(a)              
General Requirements. Shares of Company Stock issued pursuant to Stock Awards may be issued for consideration
or for no consideration, and subject to restrictions or no restrictions, as determined by the Board. The Board may establish conditions
under which restrictions on Stock Awards shall lapse over a period of time or according to such other criteria as the Board deems
appropriate. The period of time during which the Stock Award will remain subject to restrictions will be designated in the Grant
Instrument as the “Restriction Period.”

 

(b)             
Number of Shares. The Board shall determine the number of shares of Company Stock to be issued pursuant to a
Stock Award and the restrictions applicable to such shares.

 

(c)              
Requirement of Employment or Service. If the Grantee ceases to be employed by, or provide service to, the Employer
(as defined in Section 5(f)) during a period designated in the Grant Instrument as the Restriction Period, or if other specified
conditions are not met, the Stock Award shall terminate as to all shares covered by the award as to which the restrictions have
not lapsed, and those shares of Company Stock must be immediately returned to the Company. The Board may, however, provide for
complete or partial exceptions to this requirement as it deems appropriate.

 

    5

     

    

 

(d)             
Restrictions on Transfer and Legend on Stock Certificate. During the Restriction Period, a Grantee may not sell,
assign, transfer, pledge or otherwise dispose of the shares of the Stock Award except to a successor under Section 8(a). Each certificate
for Stock Awards shall contain a legend giving appropriate notice of the restrictions in the Grant. The Grantee shall be entitled
to have the legend removed from the stock certificate covering the shares subject to restrictions when all restrictions on such
shares have lapsed. The Board may determine that the Company will not issue certificates for Stock Awards until all restrictions
on such shares have lapsed, or that the Company will retain possession of certificates for Stock Awards until all restrictions
on such shares have lapsed.

 

(e)              
Right to Vote and to Receive Dividends. During the Restriction Period, the Grantee shall have the right to vote
shares subject to Stock Awards and to receive any dividends or other distributions paid on such shares, subject to any restrictions
deemed appropriate by the Board.

 

(f)                Lapse
of Restrictions. All restrictions imposed on Stock Awards shall lapse upon the expiration of the applicable
Restriction Period and the satisfaction of all conditions imposed by the Board. The Board may determine, as to any or all
Stock Awards, that the restrictions shall lapse without regard to any Restriction Period.

 

7.                 
Withholding of Taxes.

 

(a)              
Required Withholding. All Grants under this Plan shall be subject to applicable federal (including FICA), state
and local tax withholding requirements. The Employer may require that the Grantee or other person receiving or exercising Grants
pay to the Employer the amount of any federal, state or local taxes that the Employer is required to withhold with respect to such
Grants, or the Employer may deduct from other wages paid by the Employer the amount of any withholding taxes due with respect to
such Grants.

 

(b)             
Election to Withhold Shares. If the Board so permits, a Grantee may elect to satisfy the Employer’s income
tax withholding obligation with respect to a Grant by having shares withheld up to an amount that does not exceed the Grantee’s
minimum applicable withholding tax rate for federal (including FICA), state and local tax liabilities. The election must be in
a form and manner prescribed by the Board and may be subject to the prior approval of the Board.

 

8.                 
Transferability of Grants.

 

(a)              
Nontransferability of Grants. Except as provided below, only the Grantee may exercise rights under a Grant during
the Grantee’s lifetime, and a Grant shall not be subject to attachment, execution or similar process. A Grantee may not transfer
(voluntarily or involuntarily) those rights except by will or by the laws of descent and distribution or with respect to Grants
other than Incentive Stock Options, if permitted in any specific case by the Board. When a Grantee dies, the personal representative
or other person entitled to succeed to the rights of the Grantee may exercise such rights. Any such successor must furnish proof
satisfactory to the Company of his or her right to receive the Grant under the Grantee’s will or under the applicable laws
of descent and distribution. In the event of (1) any attempt by any Grantee to alienate, assign, pledge, hypothecate or otherwise
dispose of a Grant, except as provided in this Plan, or (2) the levy of any attachment, execution or similar process upon the rights
or interest hereby conferred, the Company may terminate the applicable Grant by notice to the Grantee and it shall thereupon become
null and void.

 

(b)             
Transfer of Nonqualified Stock Options. Notwithstanding the foregoing, the Board may provide in a Grant Instrument,
or subsequently approve, that a Grantee may transfer Nonqualified Stock Options to family members, or one or more trusts or other
entities for the benefit of or owned by family members, consistent with applicable securities laws, according to such terms as
the Board may determine; provided that the Grantee receives no consideration for the transfer of an Option and the transferred
Option shall continue to be subject to the same terms and conditions as were applicable to the Option immediately before the transfer.

 

    6

     

    

 

9.                 
Right of First Refusal; Repurchase Right.

 

(a)               Offer.
Prior to a Public Offering, if at any time an individual desires to sell, encumber, or otherwise dispose of shares of Company
Stock that were distributed to him or her under this Plan and that are transferable, the individual may do so only pursuant
to a bona fide written offer, and the individual shall first offer the shares to the Company by giving the Company written
notice disclosing: (i) the name of the proposed transferee of the Company Stock; (ii) the certificate number and number of
shares of Company Stock proposed to be transferred or encumbered; (iii) the proposed price; (iv) all other terms of the
proposed transfer; and (v) a written copy of the proposed offer. Within 60 days after receipt of such notice, the Company
shall have the option to purchase all or part of such Company Stock at the price and on the terms described in the written
notice; provided that the Company may pay such price in installments over a period not to exceed four years, at the
discretion of the Board.

 

(b)             
Sale. In the event the Company (or a stockholder, as described below) does not exercise the option to purchase
Company Stock, as provided above, the individual shall have the right to sell, encumber, or otherwise dispose of the shares of
Company Stock described in subsection (a) at the price and on the terms of the transfer set forth in the written notice to the
Company, provided such transfer is effected within 15 days after the expiration of the option period. If the transfer is not effected
within such period, the Company must again be given an option to purchase, as provided above.

 

(c)              
Assignment of Rights. The Board, in its sole discretion, may waive the Company’s right of first refusal
and repurchase right under this Section 9. If the Company’s right of first refusal or repurchase right is so waived, the
Board may, in its sole discretion, assign such right to the remaining stockholders of the Company in the same proportion that each
stockholder’s stock ownership bears to the stock ownership of all the stockholders of the Company, as determined by the Board.
To the extent that a stockholder has been given such right and does not purchase his or her allotment, the other stockholders shall
have the right to purchase such allotment on the same basis.

 

(d)             
Purchase by the Company. Prior to a Public Offering, if a Grantee ceases to be employed by, or provide service
to, the Employer, the Company shall have the right to purchase all or part of any Company Stock distributed to him or her under
this Plan at its then current Fair Market Value (as defined in Section 5(b)) (or at such other price as may be established in the
Grant Instrument); provided, however, that such repurchase shall be made in accordance with applicable accounting rules to avoid
adverse accounting treatment.

 

(e)              
Public Offering. On and after a Public Offering, the Company shall have no further right to purchase shares of
Company Stock under this Section 9.

 

(f)               
Stockholders Agreement. Notwithstanding the provisions of this Section 9, if the Board requires that a Grantee
execute a Stockholders Agreement (as defined below) (or other agreement containing first refusal or repurchase rights) with respect
to any Company Stock distributed pursuant to this Plan, such Grantee shall execute such Stockholders Agreement (or other such agreement)
as a condition to retaining his or her rights to such Company Stock. If such Stockholders Agreement (or other such agreement) contains
a right of first refusal or repurchase right, the provisions of this Section 9 shall not apply to such Company Stock for as long
as those provisions of the Stockholders Agreement (or other agreement) are in effect, unless the Board determines otherwise.

 

10.             
 Change of Control of the Company.

 

(a)              
Definitions.

 

As used in this Plan,
a “Change of Control” shall mean:

 

(i)                
any merger or consolidation in which voting securities of the Company possessing more than 50% of the total combined voting
power of the Company’s outstanding securities are Transferred to a person or persons different from the person holding those
securities immediately prior to such transaction and the composition of the Board following such transaction is such that the directors
of the Company prior to the transaction constitute less than 50% of the Board membership following the transaction;

 

    7

     

    

 

(ii)             
any acquisition, directly or indirectly, by a person or related group of persons (other than the Company or a person that
directly or indirectly controls, is controlled by, or is under common control with, the Company) of beneficial ownership of voting
securities of the Company possessing more than 50% of the total combined voting power of the Company’s outstanding securities;
provided, however, that, no Change of Control shall be deemed to occur by reason of the acquisition of shares of the Company’s
capital stock by an investor or group of investors in the Company in a capital-raising transaction;

 

(iii)           
any acquisition, directly or indirectly, by a person or related group of persons of the right to appoint a majority of the
directors of the Company or otherwise directly or indirectly control the management, affairs and business of the Company;

 

(iv)            
any sale transfer or other disposition of all or substantially all of the assets of the Company; or

 

(v)              
a complete liquidation or dissolution of the Company.

 

As used in this Section
10, “Transfer” shall include any sale, exchange, assignment, gift, bequest, disposition, mortgage, charge, pledge,
encumbrance, grant of a security interest or other arrangement by which possession, legal title or beneficial ownership passes
from one Person to another, or to the same Person in a different capacity, whether or not voluntarily and whether or not for value,
and including without limitation any merger or amalgamation and any agreement to effect any of the foregoing.

 

(b)             
Assumption of Grants. Upon a Change of Control where the Company is not the surviving corporation (or survives
only as a subsidiary of another corporation), unless the Board determines otherwise, all outstanding Options that are not exercised
shall be assumed by, or replaced with comparable options by the surviving corporation (or a parent or subsidiary of the surviving
corporation), and outstanding Stock Awards shall be converted to Stock Awards of the surviving corporation (or a parent or subsidiary
of the surviving corporation).

 

(c)               Other
Alternatives. Notwithstanding the foregoing, in the event of a Change of Control, the Board may take any of the
following actions with respect to any or all outstanding Grants: the Board may determine that outstanding Options shall
accelerate and become exercisable, in whole or in part, upon the Change of Control or upon such other event as the Board
determines, determine that the restrictions and conditions on outstanding Stock Awards shall lapse, in whole or in part, upon
the Change of Control or upon such other event as the Board determines, require that Grantees surrender their outstanding
Options in exchange for a payment by the Company, in cash or stock as determined by the Board, in an amount equal to the
amount by which the then Fair Market Value of the shares of Company Stock subject to the Grantee’s unexercised Options
exceeds the Exercise Price of the Options or after giving Grantees an opportunity to exercise their outstanding Options,
terminate any or all unexercised Options at such time as the Board deems appropriate. Such surrender or termination shall
take place as of the date of the Change of Control or such other date as the Board may specify. The Board shall have no
obligation to take any of the foregoing actions, and, in the absence of any such actions, outstanding Options and Stock
Awards shall continue in effect according to their terms (subject to any assumption pursuant to subsection (b)).

 

11.             
Requirements for Issuance of Shares.

 

(a)              
Stockholders Agreement. The Board may require that a Grantee become a party to a stockholders agreement, co-sale
agreement and/or a voting agreement, or any similar type of agreement to which the holders of Common Stock generally are parties
(each, a “Stockholders Agreement”), in each case, with such terms as the Board deems appropriate, with respect to any
Company Stock issued pursuant to this Plan, and as a condition to the issuance of such Company Stock in such event, the Grantee
shall be required to execute and deliver to the Company an agreement to be bound by such Stockholders Agreement.

 

    8

     

    

 

(b)             
Limitations on Issuance of Shares. No Company Stock shall be issued in connection with any Grant hereunder unless
and until all legal requirements applicable to the issuance of such Company Stock have been complied with to the satisfaction of
the Board. The Board shall have the right to condition any Grant made to any Grantee hereunder on such Grantee’s undertaking
in writing to comply with such restrictions on his or her subsequent disposition of such shares of Company Stock as the Board shall
deem necessary or advisable, and certificates representing such shares may be legended to reflect any such restrictions. Certificates
representing shares of Company Stock issued under this Plan will be subject to such stop-transfer orders and other restrictions
as may be required by applicable laws, regulations and interpretations, including any requirement that a legend be placed thereon.

 

(c)              
Lock-Up Period. If so requested by the Company or any representative of the underwriters (the “Managing
Underwriter”) in connection with any underwritten offering of securities of the Company under the Securities Act of 1933,
as amended (the “Securities Act”), a Grantee (including any successor or assigns) shall not sell or otherwise transfer
any shares or other securities of the Company during the 30-day period preceding and the 180-day period following the effective
date of a registration statement of the Company filed under the Securities Act for such underwriting (or such shorter period as
may be requested by the Managing Underwriter and agreed to by the Company) (the “Market Standoff Period”). If so requested,
the Grantee shall enter into a separate written agreement to such effect in form and substance requested by the Company or the
Managing Underwriter. The Company may impose stop-transfer instructions with respect to securities subject to the foregoing restrictions
until the end of such Market Standoff Period. Notwithstanding the foregoing, the Company may require that a Grantee execute a
Stockholders Agreement or other agreement containing lock-up provisions. If such Stockholders Agreement or other agreement contains
any lock-up or market standoff provisions that differ from the provisions of this Section 11(c), for as long as the provisions
of such other agreement are in effect, the provisions of this Section 11(c) shall not apply to such Company Stock, unless the
Board determines otherwise.

 

12.             
Amendment and Termination of This Plan.

 

(a)              
Amendment. The Board may amend or terminate this Plan at any time; provided, however, that the Board shall not
amend this Plan without stockholder approval if such approval is required in order to comply with the Code or other applicable
laws, or, after a Public Offering, to comply with applicable stock exchange requirements.

 

(b)             
Termination of This Plan. This Plan shall terminate on the day immediately preceding the tenth anniversary of
its effective date, unless this Plan is terminated earlier by the Board or is extended by the Board with the approval of the stockholders.

 

(c)              
Termination and Amendment of Outstanding Grants. A termination or amendment of this Plan that occurs after a
Grant is made shall not materially impair the rights of a Grantee unless the Grantee consents or unless the Board acts under Section
18(b). The termination of this Plan shall not impair the power and authority of the Board with respect to an outstanding Grant.
Whether or not this Plan has terminated, an outstanding Grant may be terminated or amended under Section 18(b) or may be amended
by agreement of the Company and the Grantee consistent with this Plan.

 

(d)             
Governing Document. This Plan shall be the controlling document. No other statements, representations, explanatory
materials or examples, oral or written, may amend this Plan in any manner. This Plan shall be binding upon and enforceable against
the Company and its successors and assigns.

 

13.             
Funding of This Plan. This Plan shall be unfunded. The Company shall not be required to establish any special
or separate fund or to make any other segregation of assets to assure the payment of any Grants under this Plan. In no event shall
interest be paid or accrued on any Grant, including unpaid installments of Grants.

 

14.             
Rights of Participants. Nothing in this Plan shall entitle any Employee, Key Advisor, Non-Employee Director or
other person to any claim or right to be granted a Grant under this Plan. Neither this Plan nor any action taken hereunder shall
be construed as giving any individual any rights to be retained by or in the employ of the Employer or any other employment rights.

 

15.             
No Fractional Shares. No fractional shares of Company Stock shall be issued or delivered pursuant to this Plan
or any Grant. The Board shall determine whether cash, other awards or other property shall be issued or paid in lieu of such fractional
shares or whether such fractional shares or any rights thereto shall be forfeited or otherwise eliminated.

 

16.             
Headings. Section headings are for reference only. In the event of a conflict between a title and the content
of a Section, the content of the Section shall control.

 

    9

     

    

 

17.             
 Effective Date of This Plan.

 

(a)              
Effective Date. This Plan was originally effective on July 3, 2008. The Plan was amended and restated on April
8, 2010, amended and restated on November 17, 2015, amended on July 1, 2016 and amended and restated on January 17, 2017.

 

(b)             
Public Offering. The provisions of this Plan that refer to a Public Offering, or that refer to, or are applicable
to persons subject to, section 16 of the Exchange Act or section 162(m) of the Code, shall be effective, if at all, upon the initial
registration of the Company Stock under section 12(b) or section 12(g) of the Exchange Act, and shall remain effective thereafter
for as long as such stock is so registered.

 

18.             
Miscellaneous.

 

(a)              
Grants in Connection with Corporate Transactions and Otherwise. Nothing contained in this Plan shall be construed
to limit the right of the Board to make Grants under this Plan in connection with the acquisition, by purchase, lease, merger,
consolidation or otherwise, of the business or assets of any corporation, firm or association, including Grants to employees thereof
who become Employees, or for other proper corporate purposes, or limit the right of the Company to grant stock options or make
other awards outside of this Plan. Without limiting the foregoing, the Board may make a Grant to an employee of another corporation
who becomes an Employee by reason of a corporate merger, consolidation, acquisition of stock or property, reorganization or liquidation
involving the Company, the Parent or any of their subsidiaries in substitution for a stock option or Stock Awards grant made by
such corporation. The terms and conditions of the substitute grants may vary from the terms and conditions required by this Plan
and from those of the substituted stock incentives. The Board shall prescribe the provisions of the substitute grants.

 

(b)             
Compliance with Law. This Plan, the exercise of Options and the obligations of the Company to issue shares of
Company Stock under Grants shall be subject to all applicable laws and to approvals by any governmental or regulatory agency as
may be required. With respect to persons subject to section 16 of the Exchange Act, after a Public Offering it is the intent of
the Company that this Plan and all transactions under this Plan comply with all applicable provisions of Rule 16b-3 or its successors
under the Exchange Act. In addition, it is the intent of the Company that this Plan and applicable Grants under this Plan comply
with the applicable provisions of section 162(m) of the Code, after a Public Offering, and section 422 of the Code. To the extent
that any legal requirement of section 16 of the Exchange Act or section 162(m) or 422 of the Code as set forth in this Plan ceases
to be required under section 16 of the Exchange Act or section 162(m) or 422 of the Code, that Plan provision shall cease to apply.
The Board may revoke any Grant if it is contrary to law or modify a Grant to bring it into compliance with any valid and mandatory
government regulation. The Board may also adopt rules regarding the withholding of taxes on payments to Grantees. The Board may,
in its sole discretion, agree to limit its authority under this Section.

 

(c)               Employees
Subject to Taxation Outside the United States. With respect to Grantees who are subject to taxation in countries
other than the United States, the Board may make Grants on such terms and conditions as the Board deems appropriate to comply
with the laws of the applicable countries, and the Board may create such procedures, addenda and subplans and make such
modifications as may be necessary or advisable to comply with such laws.

 

(d)             
Governing Law. The validity, construction, interpretation and effect of this Plan and Grant Instruments issued
under this Plan shall be governed and construed by and determined in accordance with the laws of the State of Delaware, without
giving effect to the conflict of laws provisions thereof.

 

    10

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00313-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00313-of-00352.parquet"}]]